UBS Group AG - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 47 filers reported holding CIDARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
11
-99.4%
0.00%
Q1 2022$1,0001,725
+15581.8%
0.00%
Q4 2021$011
-26.7%
0.00%
Q3 2021$0
-100.0%
15
-99.7%
0.00%
Q2 2021$12,000
-80.6%
5,996
-74.1%
0.00%
Q1 2021$62,000
+24.0%
23,119
-7.7%
0.00%
Q4 2020$50,000
-88.6%
25,036
-83.8%
0.00%
Q3 2020$440,000
-15.4%
154,236
+9.3%
0.00%
Q2 2020$520,000
+497.7%
141,075
+304.9%
0.00%
Q1 2020$87,000
+770.0%
34,845
+1218.9%
0.00%
Q4 2019$10,000
-44.4%
2,642
-70.8%
0.00%
Q3 2019$18,000
+28.6%
9,056
+3.8%
0.00%
Q2 2019$14,000
-51.7%
8,725
-19.8%
0.00%
Q1 2019$29,000
+31.8%
10,873
+15.2%
0.00%
Q4 2018$22,000
+10.0%
9,442
+103.5%
0.00%
Q3 2018$20,000
-47.4%
4,639
-35.8%
0.00%
Q2 2018$38,000
+153.3%
7,231
+86.8%
0.00%
Q1 2018$15,000
+50.0%
3,872
+176.6%
0.00%
Q4 2017$10,000
+900.0%
1,400
+907.2%
0.00%
Q2 2017$1,000
-90.0%
139
-89.4%
0.00%
Q1 2017$10,000
-86.5%
1,315
-81.5%
0.00%
Q4 2016$74,000
+138.7%
7,116
+167.1%
0.00%
Q3 2016$31,000
+158.3%
2,664
+172.4%
0.00%
Q3 2015$12,000978
+5047.4%
0.00%
Q2 2015$0190.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders